|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of1 Health and Kinesiology2 Intercollegiate Faculty of Nutrition3 Mechanical Engineering, Texas A&M University, College Station, Texas 77843, USA4 INSERM U890, Saint-Etienne F4023, France5 IFR 143, Saint-Etienne F42023, France6 Université Jean-Monnet, Saint-Etienne F42023, France7 Department of Applied Physiology and Kinesiology and the Center for Exercise Science, University of Florida, Gainesville, Florida 32611, USA
(Correspondence should be addressed to M D Delp; Email: mdelp{at}ufl.edu)
Osteopenia and an enhanced risk of fracture often accompany type 1 diabetes. However, the association between type 2 diabetes and bone mass has been ambiguous with reports of enhanced, reduced, or similar bone mineral densities (BMDs) when compared with healthy individuals. Recently, studies have also associated type 2 diabetes with increased fracture risk even in the presence of higher BMDs. To determine the temporal relationship between type 2 diabetes and bone remodeling structural and mechanical properties at various bone sites were analyzed during pre-diabetes (7 weeks), short-term (13 weeks), and long-term (20 weeks) type 2 diabetes. BMDs and bone strength were measured in the femora and tibiae of Zucker diabetic fatty rats, a model of human type 2 diabetes. Increased BMDs (9–10%) were observed in the distal femora, proximal tibiae, and tibial mid- shafts in the pre-diabetic condition that corresponded with higher plasma insulin levels. During short- and long-term type 2 diabetes, various parameters of bone strength and BMDs were lower (9–26%) in the femoral neck, distal femora, proximal tibiae, and femoral and tibial mid-shafts. Correspondingly, blood glucose levels increased by 125% and 153% during short- and long-term diabetes respectively. These data indicate that alterations in BMDs and bone mechanical properties are closely associated with the onset of hyperinsulinemia and hyperglycemia, which may have direct adverse effects on skeletal tissue. Consequently, disparities in the human literature regarding the effects of type 2 diabetes on skeletal properties may be associated with the bone sites studied and the severity or duration of the disease in the patient population studied.
This article has been cited by other articles:
![]() |
S. Reinwald, R. G. Peterson, M. R. Allen, and D. B. Burr Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E765 - E774. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |